Processa Pharmaceuticals Inc. (PCSA)
NASDAQ · Healthcare
Processa Pharmaceuticals Inc. Revenue 2012–2022
Processa Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2012 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Processa Pharmaceuticals Inc. revenue for the quarter ending March 31, 2023 was 0.
- Processa Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2023 was 63165, a 71.71% decrease year-over-year.
- Processa Pharmaceuticals Inc. annual revenue for 2022 was 0.
- Processa Pharmaceuticals Inc. annual revenue for 2021 was 0, a 100.00% decrease from 2016.
- Processa Pharmaceuticals Inc. annual revenue for 2016 was 5000, a 95.59% decrease from 2015.
- Processa Pharmaceuticals Inc. annual revenue for 2015 was 113425.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Processa Pharmaceuticals Inc. Market Cap — FAQ
Processa Pharmaceuticals Inc. (PCSA) market cap over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCSA's market cap history?
The chart and table above show Processa Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.